Bradley Foster & Sargent Inc. CT Reduces Holdings in Cigna Group $CI

Bradley Foster & Sargent Inc. CT trimmed its holdings in shares of Cigna Group (NYSE:CI) by 8.8% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 18,132 shares of the health services provider’s stock after selling 1,747 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Cigna Group were worth $4,837,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Assetmark Inc. increased its stake in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after purchasing an additional 5,963 shares in the last quarter. apricus wealth LLC grew its holdings in Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after purchasing an additional 8,340 shares during the period. Nisa Investment Advisors LLC grew its holdings in Cigna Group by 3.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock valued at $29,046,000 after purchasing an additional 3,814 shares during the period. OFI Invest Asset Management increased its position in Cigna Group by 8,357.8% in the fourth quarter. OFI Invest Asset Management now owns 33,070 shares of the health services provider’s stock worth $9,102,000 after buying an additional 32,679 shares in the last quarter. Finally, Polianta Ltd purchased a new stake in Cigna Group in the fourth quarter worth about $1,568,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Trading Up 0.2%

Shares of CI stock opened at $290.06 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $76.73 billion, a price-to-earnings ratio of 12.30, a price-to-earnings-growth ratio of 1.12 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The stock’s 50-day moving average price is $286.05 and its 200-day moving average price is $280.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CI. Sanford C. Bernstein upped their price target on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Jefferies Financial Group decreased their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. Royal Bank Of Canada increased their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 target price on Cigna Group in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.